ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,256Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 973

$452K Total Retail Price of All Prescriptions

Rank: 182 out of 973

421 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,860 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 551 457 1 1
LEVOTHYROXINE SODIUM 519 438 2 2
HYDROCODONE-ACETAMINOPHEN 402 188 S3 3 4
FUROSEMIDE 382 301 4 6
OMEPRAZOLE 351 268 5 5
LISINOPRIL 342 266 6 3
POTASSIUM CHLORIDE 287 207 7 9
SERTRALINE HCL 203 133 8 21
METFORMIN HCL 190 151 9 8
HYDROCHLOROTHIAZIDE 170 158 10 11
ATORVASTATIN CALCIUM 170 161 10 15
CARVEDILOL 160 124 12 27
AMLODIPINE BESYLATE 155 138 13 7
WARFARIN SODIUM 139 118 14 10
ALLOPURINOL 132 128 15 29
MELOXICAM 131 106 16 23
LOSARTAN POTASSIUM 131 112 16 19
GABAPENTIN 129 69 18 12
TRAMADOL HCL 129 87 18 18
ZOLPIDEM TARTRATE 127 95 20 20
CYCLOBENZAPRINE HCL 124 0 R 21 42
PREDNISONE 115 80 22 33
CEPHALEXIN 112 76 23 75
ATENOLOL 108 85 24 16
CITALOPRAM HBR 105 58 25 14
AMITRIPTYLINE HCL 105 60 R 25 52
CYMBALTA 99 23 27 40
SPIRONOLACTONE 97 74 28 49
RANITIDINE HCL 91 70 29 45
METOPROLOL TARTRATE 90 84 30 13
METOCLOPRAMIDE HCL 89 49 31 93
BENAZEPRIL HCL 88 86 32 62
FLUOXETINE HCL 83 54 33 56
OXYBUTYNIN CHLORIDE 81 69 34 92
FENTANYL 79 56 S2 35 53
MORPHINE SULFATE ER 76 0 S2 36 74
CIPROFLOXACIN HCL 76 57 36 57
TRIAMTERENE-HYDROCHLOROTHIAZID 75 66 38 140
DIGOXIN 73 73 39 32
GLIMEPIRIDE 70 70 40 41
CLOPIDOGREL 65 55 41 44
POLYETHYLENE GLYCOL 3350 65 43 41 36
NYSTATIN 65 43 41 149
ESTRADIOL 63 0 R 44 100
DONEPEZIL HCL 62 50 45 26
TAMSULOSIN HCL 61 31 46 28
OXYCODONE HCL 59 0 S2 47 79
ENALAPRIL MALEATE 59 48 47 55
PROPRANOLOL HCL 59 52 47 97
PAROXETINE HCL 58 41 50 66
FLUTICASONE PROPIONATE 57 38 51 35
BACLOFEN 57 0 51 123
METFORMIN HCL ER 56 44 53 58
ADVAIR DISKUS 56 26 53 60
MUPIROCIN 54 36 55 151
METHADONE HCL 54 0 S2 55 129
NAMENDA 52 28 57 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.